Capricor Therapeutics (CAPR) vs DiaMedica Therapeutics (DMAC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
DiaMedica Therapeutics (DMAC) has outperformed Capricor Therapeutics (CAPR) over the past year, gaining 16.5% versus a gain of 8.0%. Over five years, CAPR leads with a +104.5% price change compared with +94.9% for DMAC. Capricor Therapeutics is the larger company by market cap ($470.9 million vs $430.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPR | DMAC |
|---|---|---|
| Share price | $8.10 | $7.99 |
| Market cap | $470.93M | $430.87M |
| 1-day change | +4.52% | -1.72% |
| YTD return | -71.93% | +0.38% |
| 1-year return | +8.00% | +16.47% |
| 5-year return | +104.55% | +94.88% |
| EPS (TTM) | $-2.45 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.37 | $10.42 |
| 52-week low | $2.96 | $5.25 |
| Distance from 52-week high | -79.94% | -23.32% |
| Average volume | 6.83M | 177.47K |
| Shares outstanding | 58.14M | 53.93M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CAPR vs DMAC FAQ
Which is bigger, Capricor Therapeutics or DiaMedica Therapeutics?
Capricor Therapeutics (CAPR) is larger, with a market capitalization of $470.93M compared with $430.87M for DiaMedica Therapeutics (DMAC).
Which stock has performed better over the past year, CAPR or DMAC?
DMAC returned +16.47% over the past 12 months, compared with +8.00% for CAPR (price return, excluding dividends). Past performance does not predict future results.
Are Capricor Therapeutics and DiaMedica Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.